Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 19.91 CNY -0.8% Market Closed
Market Cap: 56.7B CNY
Have any thoughts about
Shanghai Pharmaceuticals Holding Co Ltd?
Write Note

Shanghai Pharmaceuticals Holding Co Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Pharmaceuticals Holding Co Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Pre-Tax Income
ÂĄ7.2B
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
7%
Sinopharm Group Co Ltd
HKEX:1099
Pre-Tax Income
ÂĄ18.2B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
13%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Pre-Tax Income
ÂĄ2.9B
CAGR 3-Years
-13%
CAGR 5-Years
6%
CAGR 10-Years
15%
C
China National Medicines Corp Ltd
SSE:600511
Pre-Tax Income
ÂĄ2.9B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
17%
Huadong Medicine Co Ltd
SZSE:000963
Pre-Tax Income
ÂĄ3.9B
CAGR 3-Years
12%
CAGR 5-Years
4%
CAGR 10-Years
13%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Pre-Tax Income
ÂĄ2B
CAGR 3-Years
-4%
CAGR 5-Years
2%
CAGR 10-Years
10%
No Stocks Found

Shanghai Pharmaceuticals Holding Co Ltd
Glance View

Market Cap
56.7B CNY
Industry
Health Care

Shanghai Pharmaceuticals Holding Co Ltd, a giant in China's pharmaceutical industry, operates with a dual-engine strategy that seamlessly combines manufacturing and distribution. Established in the bustling metropolis of Shanghai, the company has swiftly become a cornerstone of China's healthcare landscape. Its manufacturing arm is a powerhouse of innovation and production, turning out a vast array of pharmaceutical products that encompass both traditional Chinese medicine and modern pharmaceuticals. These products range from patented medicines to essential generics, entering hospitals, clinics, and retail pharmacies nationwide, all the while feeding a robust supply chain that caters to the country's vast and diverse market needs. On the flip side, Shanghai Pharmaceuticals' extensive distribution network is the lifeline that ensures these vital medicines reach their destinations safely and efficiently. In an era where logistics and supply chain management are pivotal, the company excels through an advanced distribution system that connects manufacturers with end-users across China. This network is bolstered by strategic partnerships and a commitment to technological advancement, allowing the company to maintain agility and reliability in an ever-evolving market. Revenue streams flow not just from product sales but are heavily supplemented through strategic partnerships and services that enhance accessibility and affordability for healthcare providers and patients alike. As one of the top pharmaceutical firms in China, Shanghai Pharmaceuticals is adept at maneuvering the intricacies of healthcare demands, regulatory landscapes, and competitive dynamics, carving its niche as a leader in both innovation and distribution efficiency.

Intrinsic Value
45.73 CNY
Undervaluation 56%
Intrinsic Value
Price

See Also

What is Shanghai Pharmaceuticals Holding Co Ltd's Pre-Tax Income?
Pre-Tax Income
7.2B CNY

Based on the financial report for Sep 30, 2024, Shanghai Pharmaceuticals Holding Co Ltd's Pre-Tax Income amounts to 7.2B CNY.

What is Shanghai Pharmaceuticals Holding Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
7%

Over the last year, the Pre-Tax Income growth was -7%. The average annual Pre-Tax Income growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been -5% over the past three years , 5% over the past five years , and 7% over the past ten years .

Back to Top